Semaglutide vs Retatrutide
Semaglutide is the proven standard; retatrutide is the next frontier. One is FDA-approved with years of real-world data, the other produced the highest weight loss numbers ever seen in clinical trials but isn't available yet.
| Metric | Semaglutide | Retatrutide |
|---|---|---|
| Category | Weight Management | Weight Management |
| Default Unit | mg | mg |
| Vial Sizes | 2, 3, 5, 10 | 10, 15 |
| Dose Range | 0.25–2.4 mg | 1–12 mg |
| Frequency | Weekly | Weekly |
| Stability | 28 days | 30 days |
| Powder Storage | Freezer −20°C | Freezer −20°C |
| Reconstituted | Fridge 2–8°C | Fridge 2–8°C |
Single vs Triple Agonist
Semaglutide targets GLP-1 only. Retatrutide targets GLP-1, GIP, and glucagon receptors — three metabolic pathways simultaneously. The glucagon component is unique: it increases energy expenditure and promotes fat oxidation directly, which may explain the enhanced weight loss results.
Weight Loss Data
Semaglutide 2.4 mg: ~15–17% average weight loss (68 weeks, Phase 3). Retatrutide 12 mg: ~24.2% average weight loss (48 weeks, Phase 2). The retatrutide number is remarkable — and it was achieved in a shorter timeframe. However, Phase 2 trials are smaller and may not fully replicate in Phase 3.
Availability
Semaglutide: FDA-approved, widely available via prescription (Ozempic, Wegovy), available through compounding pharmacies. Retatrutide: NOT FDA-approved, currently in Phase 3 clinical trials, available only through research channels. Earliest possible FDA approval: 2026–2027.
⚖️ The Verdict
Semaglutide is available now with proven safety data. Retatrutide shows superior weight loss potential but is investigational. If you need a solution today, semaglutide (or tirzepatide) is the answer. Retatrutide is the one to watch for the future.
More Comparisons
Semaglutide vs Tirzepatide
Semaglutide and tirzepatide are the two most prescribed weight management peptides in the world. Both require weekly injections and gradual titration, but they work through different mechanisms and produce different outcomes.
BPC-157 vs TB-500
BPC-157 and TB-500 are the two most popular recovery peptides. They address healing from fundamentally different angles and are frequently combined, but understanding when to use each — or both — matters for optimizing protocols.
CJC-1295 vs Ipamorelin
CJC-1295 and Ipamorelin are the two most commonly used growth hormone peptides. They work through different receptor systems and are synergistic when combined, which is why the CJC + Ipamorelin blend is so popular.